Article info
Chest clinic
Case based discussions
A case for the therapeutic use of perfluorocarbon in pulmonary atelectasis
- Correspondence to Dr Andrew Durward, Paediatric Intensive Care Unit, Evelina Children's Hospital, Westminister Rd, London SE1 7EH, UK; Andrew.Durward{at}gstt.nhs.uk
Citation
A case for the therapeutic use of perfluorocarbon in pulmonary atelectasis
Publication history
- Received March 21, 2016
- Revised November 10, 2016
- Accepted November 19, 2016
- First published December 20, 2016.
Online issue publication
April 10, 2017
Article Versions
- Previous version (20 December 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/